Clinical Accuracy of Continuous Glucose Monitoring Immediately After Kidney Transplant in Patients With Type 2 Diabetes
Authors' conclusion
CGM provided accurate blood glucose measurements compared with POCT and serum glucose values in patients with type 2 DM after kidney transplant. When used in this patient population, CGM devices have the potential to improve clinical outcomes through earlier detection and intervention for glycemic excursions.
Study context
- Population
- Kidney transplant recipients aged ≥18 years with T2D, immediate postoperative period; 82% male, mean age 58 ± 9.69 years, mean BMI 30 ± 6.41 kg/m², baseline mean HbA1c 6.7 ± 1.07%
- Participants
- 327 vs 72
- Comparison
- Blinded continuous glucose monitoring (CGM) vs point-of-care testing (POCT) and serum glucose
- CGM vs POCTn = 327
- CGM vs serum glucosen = 72
- Outcome
- Accuracy of CGM vs POCT and serum glucose: bias, absolute relative difference and Clarke Error Grid Analysis
- Follow-up
- Immediate postoperative period
Methodological detailsprospective, blinded CGM, CGM sampled interstitial glucose every 15 minutes
- Prospective
- Blinded CGM
- CGM sampled interstitial glucose every 15 minutes
Performance
As reported in the abstract
Clarke Error Grid zones and mean absolute relative difference
Zone A
Zone B
Zones A+B
Mean absolute relative difference
Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.
Original publication
Clinical Accuracy of Continuous Glucose Monitoring Immediately After Kidney Transplant in Patients With Type 2 Diabetes. Endocr Pract. Published 7 May 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →